Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5399-92-8

Post Buying Request

5399-92-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5399-92-8 Usage

Description

4-Chloro-1H-pyrazolo[3,4-d]pyrimidine is a chemical compound belonging to the class of pyrazolopyrimidines. It is characterized by the presence of a chlorine atom at the 4th position and a pyrimidine ring fused to a pyrazole ring. This pale yellow solid exhibits unique chemical properties and has been found to possess a SK channel blocker effect, which is significant in various applications.

Uses

Used in Pharmaceutical Industry:
4-Chloro-1H-pyrazolo[3,4-d]pyrimidine is used as a SK channel blocker for its potential role in the development of therapeutic agents targeting ion channels. The SK channel blocker effect of this compound makes it a promising candidate for the treatment of various conditions, such as neurological disorders and cardiovascular diseases, where ion channel modulation is crucial.
Used in Chemical Research:
As a chemical compound with distinct properties, 4-Chloro-1H-pyrazolo[3,4-d]pyrimidine is also used in chemical research for the synthesis of novel molecules and the exploration of new chemical reactions. Its unique structure and functional groups make it an interesting starting point for the development of new compounds with potential applications in various fields.
Used in Material Science:
The pale yellow solid nature of 4-Chloro-1H-pyrazolo[3,4-d]pyrimidine may also find applications in material science, particularly in the development of new materials with specific optical, electronic, or mechanical properties. 4-Chloro-1H-pyrazolo[3,4-d]pyrimidine's chemical structure and properties can be exploited to create novel materials with tailored characteristics for various industrial applications.

Check Digit Verification of cas no

The CAS Registry Mumber 5399-92-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,9 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5399-92:
(6*5)+(5*3)+(4*9)+(3*9)+(2*9)+(1*2)=128
128 % 10 = 8
So 5399-92-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H3ClN4/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H,7,8,9,10)

5399-92-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloro-1H-Pyrazolo[3,4-d]Pyrimidine

1.2 Other means of identification

Product number -
Other names 4-Chloro-1H-pyrazolo[3,4-d]pyrimidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5399-92-8 SDS

5399-92-8Relevant articles and documents

Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRAFV600E and VEGFR-2 dual inhibitors

Wang, Yuanyuan,Wan, Shanhe,Li, Zhonghuang,Fu, Yu,Wang, Guangfa,Zhang, Jiajie,Wu, Xiaoyun

, p. 210 - 228 (2018/06/12)

Aiming to explore novel BRAFV600E and VEGFR-2 dual inhibitors, a series of 1H-pyrazolo[3,4-d]pyrimidine derivatives were designed, synthesized and biologically evaluated in this study. Most of the synthesized 1H-pyrazolo[3,4-d]pyrimidine compounds displayed moderate to high potent activity in both enzymatic and cellular proliferation assays. Among these compounds, 9e, 9g, 9m and 9u showed remarkably high inhibitory activities against both BRAFV600E and VEGFR-2 kinase comparable to positive control Sorafenib. Particularly, compound 9u also showed potent anti-proliferative activity against BRAFV600E-expressing A375 (IC50 = 1.74 μM) and H-29 (IC50 = 6.92 μM) as well as VEGFR-2-expressing HUVEC (IC50 = 5.89 μM), which was also comparable to Sorafenib. Furthermore, kinase selectivity profile showed that 9u had almost poor or no significant inhibitory activity against wild-type BRAF and 15 other tested protein kinases. Flow cytometric analysis showed that compound 9u mainly arrested the A375 and HUVEC cell lines in the G0/G1 stage with a concentration-dependent effect. In addition, the molecular docking and molecular dynamics simulations suggested that 9u adopted a similar binding pattern with Sorafenib at the ATP-binding sites of BRAFV600E and VEGFR-2. Taken together, these results indicated that compound 9u may serve as novel lead compound in research on more effective BRAFV600E and VEGFR-2 dual inhibitors.

(1H-pyrazolo[3,4-d]pyrimidine)-4-amino derivative and application of same as IDO inhibitor to drug preparation

-

Paragraph 0049; 0050, (2017/08/31)

The invention discloses a (1H-pyrazolo[3,4-d]pyrimidine)-4-amino derivative and a preparation method thereof, and application of the derivative as an IDO inhibitor. The derivative provided by the invention can be used for preventing and/or treating a plurality of diseases, such as Alzheimer's disease, cataract, infections related to cellular immune activation, autoimmune diseases, AIDS, cancers, depression or metabolic disorder of tryptophan.

1-(2-tetrahydropyrane)-1H-pyrazole[3, 4-d] pyrimidine compound having anti-tumor activity and preparation method thereof

-

Paragraph 0049; 0050; 0051; 0052, (2017/08/28)

The invention discloses a 1-(2-tetrahydropyrane)-1H-pyrazole[3, 4-d] pyrimidine compound having anti-tumor activity. A general formula of the compound is shown as follows. The invention further discloses a synthesis method of the compound and a medicinal composition containing the compound. The invention further discloses application of the medicinal composition in treating diseases caused by protein kinase activity abnormality. The pyrazole [3, 4-d] pyrimidine compound which is novel in structure and remarkable in anti-tumor activity is developed. The compound can be used as a double-target inhibitor of BRAF/VEGFR-2 kinase and has good effect and wide application prospect in the aspect of treating the diseases caused by protein kinase activity abnormality.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5399-92-8